Cargando…
Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).
Twenty-eight patients with progressive symptomatic bone metastases from breast cancer received (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) 30 mg in 500 ml of 0.9% saline infused over 2 h every 14 days. No other systemic therapy for breast cancer was prescribed. All patients had progresse...
Autores principales: | Coleman, R. E., Woll, P. J., Miles, M., Scrivener, W., Rubens, R. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246822/ https://www.ncbi.nlm.nih.gov/pubmed/3219273 |
Ejemplares similares
-
3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer.
por: Coleman, R. E., et al.
Publicado: (1987) -
Bisphosphonates and bone metastases.
por: Morton, A. R., et al.
Publicado: (1988) -
Diaquabis(dihydrogen 3-azaniumyl-1-hydroxypropylidene-1,1-diphosphonato-κ(2)
O,O′)cobalt(II)
por: Tsaryk, Natalia V., et al.
Publicado: (2011) -
The clinical course of bone metastases from breast cancer.
por: Coleman, R. E., et al.
Publicado: (1987) -
Electrochemistry
and Stability of 1,1′-Ferrocene-Bisphosphonates
por: Egger, Melissa, et al.
Publicado: (2023)